Nebco25 Venue

The state-of-the-art life sciences hub was designed by Michael Green Architecture (MGA) in partnership with Svigals + Partners and built by Winstanley Enterprises, a firm known for its commitment to advancing bioscience infrastructure.

101 College Street, New Haven, CT

The building is home to leading tenants including BioLabs, Yale Ventures, Yale University, and Alexion Pharmaceuticals (a subsidiary of AstraZeneca), making it a cornerstone of the city’s rapidly expanding biotech ecosystem. Yale Ventures, a key tenant, plays a critical role in fostering university-led innovation by helping researchers and entrepreneurs translate breakthrough discoveries into commercial applications.

Additionally, the 52,000-square-foot BioLabs incubator offers premier lab space and business resources for early-stage biotech startups, while dedicated lab-classroom spaces for New Haven Public Schools integrate education into this hub of scientific discovery.

As a centerpiece of New Haven’s Downtown Crossing initiative, 101 College Street is a catalyst for economic growth and connectivity, seamlessly linking the Medical District, Union Station, and the Central Business District through smart urban redevelopment.

Positioned in New England’s second-largest bioscience hub, this premier location offers unparalleled access to top-tier research institutions, venture capital, and a thriving biotech community.

In 2025, NEBCO.org will transform this cutting-edge venue into the epicenter of life sciences leadership, utilizing the first-floor event space to host NEBCO25, its flagship industry conference. Bringing together top biotech executives, investors, and innovators, NEBCO25 at 101 College Street will reinforce the building’s status as the premier destination for bioscience collaboration, thought leadership, and innovation.

Developed by: Winstanley Enterprises
Building Design: Michael Green Architecture